Cargando…
Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
Autores principales: | Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222405/ https://www.ncbi.nlm.nih.gov/pubmed/35765466 http://dx.doi.org/10.1016/j.xkme.2022.100502 |
Ejemplares similares
-
COVID-19 vaccination and lung transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023) -
COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)